Valuation: Sartorius AG

Market Cap 15.09B 17.31B 14.29B 12.93B 24.2B 1,660B 24.42B 171B 65.77B 843B 64.96B 63.53B 2,704B P/E 2026 *
63.6x
P/E 2027 * 49.2x
Enterprise Value 18.67B 21.41B 17.68B 16B 29.94B 2,053B 30.2B 211B 81.35B 1,043B 80.35B 78.58B 3,344B EV / Sales 2026 *
5.02x
EV / Sales 2027 * 4.5x
Free-Float
35.87%
Yield 2026 *
0.33%
Yield 2027 * 0.4%
1 week+2.33%
Current month-2.74%
1 month+1.90%
3 months+4.46%
6 months+16.18%
Current year-2.58%
1 week 226.5
Extreme 226.5
243.8
1 month 226.3
Extreme 226.3
254.2
3 years 168.35
Extreme 168.35
383.4
5 years 168.35
Extreme 168.35
629.6
10 years 63.5
Extreme 63.505
629.6
Manager TitleAgeSince
Chief Executive Officer 59 29/06/2025
Director of Finance/CFO 55 31/03/2024
Chief Operating Officer 70 31/12/2000
Director TitleAgeSince
Director/Board Member 62 31/08/2002
Chairman 69 18/07/2017
Director/Board Member 77 28/11/2011
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%-1.94%+22.46%-30.50% 17.14B
+1.59%+1.81%+22.46%-30.44% 17.14B
-0.23%+7.58%-41.87%+53.83% 1.88B
-1.88%-4.60%-30.34%+15.52% 886M
0.00%-0.11%+60.89%-2.02% 778M
+1.32%-19.51%-62.76%-85.78% 729M
0.00%-7.14%-38.93%-51.20% 631M
+1.52%-6.97%-41.71%-54.61% 567M
+3.16%+5.15%-44.54%-39.93% 425M
-0.50%+1.12%+64.78%+55.97% 412M
Average +0.55%-3.85%-8.96%-16.91% 2.61B
Weighted average by Cap. +1.20%-0.50%+15.40%-25.88%

Financials

2026 *2027 *
Net sales 3.72B 4.27B 3.52B 3.19B 5.97B 409B 6.02B 42.04B 16.22B 208B 16.02B 15.66B 667B 4.08B 4.68B 3.86B 3.5B 6.54B 449B 6.6B 46.1B 17.78B 228B 17.56B 17.18B 731B
Net income 255M 293M 242M 219M 410M 28.09B 413M 2.89B 1.11B 14.27B 1.1B 1.08B 45.75B 329M 377M 311M 282M 527M 36.14B 531M 3.71B 1.43B 18.35B 1.41B 1.38B 58.86B
Net Debt 3.58B 4.1B 3.39B 3.06B 5.73B 393B 5.78B 40.39B 15.58B 200B 15.39B 15.05B 641B 3.27B 3.75B 3.1B 2.8B 5.24B 360B 5.29B 36.94B 14.25B 183B 14.07B 13.76B 586B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
-
Date Price Change
16/09/26 €241.30 +1.47%
15/09/26 €237.80 +4.48%
14/09/26 €227.60 -1.90%
11/09/26 €232.00 +0.91%
10/09/26 €229.90 -2.50%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
242.40EUR
Average target price
271.74EUR
Spread / Average Target
+12.10%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!